Background {#Sec1}
==========

Patients with more than one chronic disease are commonly defined as multimorbid \[[@CR1]\]. Multimorbidity is a highly prevalent condition. In fact, in the United States of America 48% of patients older than 65 years, suffer from more than three chronic diseases. This population accounts for 89% of the annual Medicare's budget in the USA \[[@CR2]\]. When multimorbidity is defined as suffering from at least three chronic diseases, 62% of German patients in general practice older than 65 years are multimorbid \[[@CR3]\]. Therefore, multimorbid patients are prevalent in general practice.

Treating the individual diseases of multimorbid patients in accordance with the specific guidelines for the single disease is the most common way to deliver care \[[@CR4]\]. This approach carries the danger of leading to an overall deterioration of the health status of multimorbid patients \[[@CR5], [@CR6]\]. These challenges intensify with the number of diseases to treat \[[@CR7]\].

Limitations for treating these patients described back in 2005 such as drug interactions or guideline related recommendations that contradict each other are still relevant today \[[@CR8]\]. To date very few guidelines primarily focus on multimorbidity \[[@CR9]--[@CR11]\]. Therefore, optimization of care for this population is a high-priority task for health care. Currently, new recommendations for improved treatment of multimorbid patients using ehealth, e.g. decision support systems are being published \[[@CR6], [@CR12]\].

The term ehealth describes the general use of electronic devices or systems in medical care. One aspect of ehealth is the application of big data analysis techniques. The term "Big Data" was introduced in 1997 \[[@CR13]\]. Commonly big data analytics are defined by the "3Vs": increasing *volume* of data, the high *velocity* of data, and the *variety* of data \[[@CR14]--[@CR16]\]. It is hypothesized that big data analytics have the ability to reveal patterns in patient data that could not be identified with more traditional methods of data analysis \[[@CR17]\].

However, there are no cut off values that clearly determine the point at which data starts being big. Still, big data analytics might have the potential to be a useful addition to the treatment of multimorbid patients.

The aim of this review was to evaluate to what degree the application of big data analytics could assist general practitioners in treating multimorbid patients.

Methods {#Sec2}
=======

Search strategy {#Sec3}
---------------

Two of the authors (AW, DW) conducted an organized computerized literature search for studies that utilized big data analytics of patient data in order to treat multimorbid patients. This review followed the guidelines of the PRISMA Extension for Scoping Reviews (PRIMSA-ScR) \[[@CR18]\].

In January 2018, the databases PubMed, The Cochrane Library, and Web of Science were searched. In order to detect all areas of Big Data Analytics, a complex search strategy was developed, using the terms "big data", "health analytics", "healthcare informatics", "electronic health records", "databases", "data collection system", "electronic data capture", "data management system", "deep learning", "electronic medical record", "machine learning", "medical data", "huge data", "electronic patient record", "datamining", "data analysis", "reinforcement learning", "decision support system", "predictive analytics", "reasoning" and "inference". In order to identify studies dealing with big data analytics in the context of multimorbidity, search terms were combined with the terms "multimorb\*" and "multi-morb\*".

The terms "general practitioner" or "general practice" were deliberately not included in the search terms to ensure that as many articles as possible on the topic of multimorbidity were included. Relevance to general practice was individually assessed in the screening process.

Additionally, a search of grey literature with Google Scholar was conducted. For this search the terms "multimorbidity AND "big data" AND ("general practice" OR "gp")" were consented within the research group under the advisement of an expert in computer sciences and used to keep the number of results manageable. Patents and citations were excluded. The search in Google Scholar was performed using the "Private-Setting" in order to produce replicable results.

The results of the searches were imported into the web service Covidence ([www.covidence.org](http://www.covidence.org)) which was used in the further review process. The complete search strategy is available in the supplemental material (Additional file [1](#MOESM1){ref-type="media"}).

No review protocol was registered for this scoping review.

Study screening {#Sec4}
---------------

After the exclusion of duplicates, 2392 article were included in the review process. Two reviewers (AW, DW) independently screened the titles, abstracts, and subsequently the full-text articles. Discrepancies during the screening process were discussed during regular consensus meetings. A third reviewer (JS) was consulted as needed.

Eligibility criteria {#Sec5}
--------------------

The authors are members of the "Center for Open Innovation in Connected Health (COPICOH)" at the University of Lübeck. In this center, computer scientists as well as researchers from a variety of health disciplines are working together. The authors held consensus meetings with this research group in order to define, what articles were to be included. It was decided that studies that used standard statistical methods, e.g. large cohort studies that examined data from electronic health records, were not deemed eligible.

After the title and abstract screening, 29 full-texts were screened. Of those full-texts 23 articles were excluded after discussion within the research team because they either did not conduct big data analytics as defined by the authors, did not focus on multimorbidity or were not relevant for general practice.

Finally, six articles were included in the data extraction. For better traceability, the entire screening process is visualized using the PRISMA Flow Chart. (see Fig. [1](#Fig1){ref-type="fig"}).Fig. 1PRISMA Flow Chart

Data extraction {#Sec6}
---------------

Studies were not filtered by type of study, publication year or language. Validity of studies was evaluated based on the judgement of two independent researchers (AW, DW). The data extraction from the included studies was done by AW and a scientific researcher in the field of computer sciences and consented with all authors.

Extracted data was the publication year, the country of origin, the aim of the study, the number of examined datasets, the used method of data analyses, and the outcome. The Results of the data extraction are summarized in Table [1](#Tab1){ref-type="table"}.Table 1Summarized characteristics of included studiesAuthorsYearCountryAimsNo. of used observationsMethod of data analysisOutcomeAndriopoulou F, et al. \[[@CR19]\]2013GreeceManaging patients suffering from chronic conditions.30Random ForestFramework that identifies the necessity to deliver personalized health services by specialists when they are most appropriate.Schäfer I, et al. \[[@CR20]\]2014GermanyDepicting which diseases are associated with each other on person-level in multimorbid patients and which ones are responsible for the overlapping of multimorbidity clusters.98.619 (72.548 for replication analyses)Analysis based on clustering techniquesModel for the association of diseases to each other. Identification of diseases that form a multimorbidity cluster as well as the identification of diseases responsible for overlapping multimorbidity clusters.Marx P, et al. \[[@CR21]\]2015HungaryInvestigating a systems-based approach for the use of separated large-scale multimorbidity data to explore common latent factors of related diseases.117.803 (subset of the UK Biobank)MCMC on a Bayesian networkBayesian, multivariate, system-based approach to identify shared latent factors that could cause multi-morbid diseases without interpreting these factors.Boshuizen HC, et al. \[[@CR22]\]2017NetherlandsDetermining the magnitude of the difference in the burden of a risk factor with different calculation methods.Not defined. Study based on the Global Burden of disease database.Temporal counterfactual reasoningDynamic modelling with the DYNAMO-HIA Method estimates the gain in Disability Adjusted Life Years (DALYs) obtained by eliminating exposure to a risk factor more accurately than other established methods.Kalgotra P, et al. \[[@CR23]\]2017USAAddressing the co-occurrences of diseases using network analysis while putting a special focus in disparities by gender.22.1 millionNetwork analysisIdentification of different multimorbidity clusters for male and female patients with a prevalence of higher comorbidities in females than males.Nicholson K, et al. \[[@CR24]\]2017CanadaDevelopment of the Multimorbidity Cluster Analysis Tool and Toolkit to identify distinct clusters within patients living with multimorbidity.75.000Analysis based on clustering techniquesDownloadable Toolkit for analysis and description of combination and permutation of diseases in large datasets of multimorbid patients.

Results {#Sec7}
=======

Of the 220 results in the "grey literature", none were deemed eligible and consequently were not among the included articles. All of the included articles were published in English. None of these articles used the keyword or term "Big Data". However, after discussing this within the researcher group, six papers were included. They originated from Greece, Germany, Hungary, the Netherlands, the United States, and Canada \[[@CR19]--[@CR24]\]. The oldest article was published 2013 the latest in 2017.

Four of the articles dealt with the analysis of large data sets of multimorbid patients to analyze or find patterns in the combinations of diseases in these samples \[[@CR20], [@CR21], [@CR23], [@CR24]\]. Although the main objectives of the articles may sound similar, the specific focus of each of these articles was a different one. One article proposed a framework for the management of treatment for multimorbid patients who suffered from COPD \[[@CR19]\]. The sixth article presented a new dynamic modelling approach to predict the gain in Disability Adjusted Life Years obtained by eliminating exposure to a risk factor more precisely than other models \[[@CR22]\].

Another result of this review was that there were no precise definitions for "Big Data" in the screened articles. Furthermore, there were no defined cut-off values to specify at which point the levels of volume, velocity or variety of data are sufficiently high to clearly define them as "Big".

Discussion {#Sec8}
==========

The aim of this review was to evaluate to what degree big data analytics are already supporting general practitioners in treating multimorbid patients.

Altogether, we identified only one article addressing the approach of improving the treatment of multimorbid patients with COPD by using techniques that are related to big data analytics \[[@CR19]\]. However, the approach proposed in this paper has to be further validated including more patients and a broader variety of diseases.

These limitations are in line with other reviews that addressed the benefits of big data analytics for Diabetes type 1 and 2 and Alzheimer's disease \[[@CR25], [@CR26]\].

The other five included articles did not present direct recommendations for the treatment of multimorbid patients. However, they utilized methods and techniques to develop models that could, upon further investigation, shed a better light on the understanding of the underlying patterns for multimorbidity. It would be reasonable to verify these models for the analysis of multimorbidity clusters of other datasets to further the understanding of multimorbidity and then integrate these models into the medical decision framework for treating patients. This missing step of integration is also commonly found in reviews addressing big data analytics in health care \[[@CR27]--[@CR29]\].

Furthermore, we found a lack of clear definitions for the "3 V's" or the term "Big Data" in general. In other reviews on big data analytics in health care settings, these terms are also only implicitly described, but their definition is usually not included \[[@CR27], [@CR28]\].

Although common expectations are, that big data analytics will have a great variety of applications in the field of multimorbid patient treatment in the future \[[@CR30]\], this review that found only one study that has direct implications for treatment puts this portrayal in perspective.

These findings might suggest an interface problem between different scientific disciplines that do research in the field of big data. For the clinician finding reliable evidence for the benefit of applying big data analytics to improve treatment is crucial. However, they usually do not have the competence in validating algorithms. Computer scientists may be more interested in developing algorithms for a more generic problem than to apply an algorithm in a specific clinical setting. Therefore, there may be the need for an academic discipline that focuses on the implementation of algorithms into practice. One example of a future application for big data analytics in health care could be the implementation of big data algorithms into medical apps for mobile devices. There are already a number of studies that investigate the possible benefits of these apps \[[@CR31]\].

Strengths and limitations {#Sec9}
-------------------------

This is to our knowledge the first review that addresses applying big data analytics in the treatment of multimorbid patients in general practice. Journals commonly included in databases used by health care professionals might not be the ones researcher working in the field of big data analytics are publishing their results in, leading to a bias in our findings.

Conclusions {#Sec10}
===========

One study was found that presents an approach for treating a group of multimorbid patients using big data techniques. Terms pertaining to big data analytics are not defined in studies applying these methods. Over all, there seems to be a mismatch between the perceived presence and usage of big data in health care and existing literature in databases commonly used by health care professionals. It seems highly relevant to form interdisciplinary research environments in which experts in implementing computer sciences and health care professionals work together to evaluate the benefits of big data analysis techniques for the treatment of patients.

Additional file
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Additional file 1:Search Strategy.pdf. Detailed Information on search strategy. Information on search strategy, search results, and exclusion criterias. (PDF 47 kb)
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